TakedaandProtagonistAnnounceU.S.FoodandDrugAdministrationAcceptsNewDrugApplicationandGrantsPriorityReviewforRusfertideasaPotentialFirst-in-ClassTherapyforPolycythemiaVera
===2026/3/2 17:48:45===
Exchange Commission. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements, whether as a result of new information, future events, or otherwise, after the date of this press release.
Contacts
Takeda Media Contacts:
Japanese Media
Tsuyoshi Tada
tsuyoshi.tada@takeda.com
U.S. and International Media
Emy Gruppo
emy.gruppo@takeda.com
Protagonist Investor Relations Contact
Corey Davis, Ph.D.
LifeSci Advisors
cdavis@lifesciadvisors.com
+1 212 915 2577
Protagonist Media Relations Co
=*=*=*=*=*=
当前为第19/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页